Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

Clinical trial NCT00150657 · UNKNOWN

Trial details

NCT number: NCT00150657
Sponsor: St. John Providence Health System
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2004-11-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.